| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |